Investors in Technology

Andurance Ventures is an independent technology venture capital firm based in London. Specializing in technology investments, Andurance Ventures focuses on identifying and supporting innovative startups with high growth potential. They provide strategic capital and operational support to help entrepreneurs scale their businesses and achieve market leadership. Andurance Ventures' commitment lies in fostering innovation and driving sustainable growth in the technology sector, leveraging their expertise and network to create value for both investors and portfolio companies.

Acceleris Capital, under KPMG Acceleris, specializes in arranging new capital for SMEs and makes direct investments in technology-based companies. Based in central Manchester, we cater to funding, investment, and advisory needs, offering a unique model that supports companies from startup to exit. Our approach not only reassures our introduced investors but also provides ongoing mentoring and support during critical phases of an SME's lifecycle. We have successfully introduced over £150 million into UK SMEs, primarily through EIS (Enterprise Investment Scheme), and have executed successful exits for shareholders. At KPMG Acceleris, we continue to collaborate with some of the nation's most promising and disruptive companies.

SPWOne, we were established by British entrepreneur and businessman Sir Peter Wood to invest in and support a range of innovative businesses across their lifecycle. Led by Sir Peter Wood and our experienced team, we have a global reach and a track record of substantial value creation. We are committed to partnering with ambitious entrepreneurs and driving growth through strategic investments and operational support.

Amadeus Capital Partners, we are a global technology investor headquartered in London, UK, with an office in Cambridge, UK. Since our founding in 1997, we have specialized in investing in high-growth technology companies across sectors such as Artificial Intelligence, Digital Health, Cybersecurity, Enterprise Software, and FinTech. Our track record demonstrates our commitment to backing ambitious entrepreneurs and supporting them in scaling their businesses internationally. We provide early-stage to growth-stage funding, partnering with founders from inception through to exit. Known for our deep sector expertise and global network, we take a hands-on approach to building successful and sustainable companies.

MVM Life Science Partners, we are a specialized healthcare investment firm focused on early-stage and growth-stage companies in the life sciences sector. Founded in 1997 and headquartered in London, our firm invests globally in innovative biopharmaceuticals, medical technology, diagnostics, and digital health companies. Our approach combines deep sector expertise with strategic support to help our portfolio companies achieve their full potential. We have a strong track record of supporting groundbreaking therapies and technologies that make a significant impact on healthcare outcomes worldwide.

Phystech Ventures is an early-stage venture capital firm specializing in deep technology (deeptech) investments. With a focus on next-generation computing, life sciences, energy, mobility, and space sectors, Phystech Ventures identifies and supports startups at the forefront of technological innovation. The firm provides critical funding and strategic support to help these companies develop breakthrough technologies and scale their operations. Phystech Ventures' investment strategy is driven by a commitment to advancing transformative innovations that address global challenges and drive sustainable growth. For entrepreneurs seeking early-stage investment in deeptech sectors, Phystech Ventures offers expertise and resources to propel innovation forward.

UCL Business (UCLB), we are at the forefront of technology transfer and commercialization, serving as the commercialization arm of University College London (UCL). Our mission is to maximize the impact of UCL's research by transforming innovative discoveries into real-world applications and products. We specialize in facilitating partnerships with industry, licensing technologies, and supporting the formation of spin-out companies. We play a pivotal role in bridging academia and industry, providing strategic advice, intellectual property management, and business development support to researchers and entrepreneurs. Our dedicated team is committed to driving innovation and economic growth through effective technology commercialization.

eureKARE is a visionary investment firm dedicated to advancing synthetic biology innovation throughout Europe. With a firm belief in the transformative potential of synthetic biology to address global health and environmental challenges, eureKARE's seasoned team is committed to leveraging Europe's burgeoning expertise in this field. By pioneering a novel startup creation and development model, eureKARE fosters a vibrant ecosystem of early and later-stage ventures through its network of biotech studios. These studios serve as pivotal bridges between academia and industry, accelerating innovations into robust companies equipped to thrive and deliver societal benefits.

Look AI Ventures (LAIV) is the first investment fund in the Czech Republic focusing exclusively on early-stage AI startups,offering new investors high returns and leveraging the AI Startup Incubator's expertise and network.Our team of seasoned managers, entrepreneurs, and technology and AI experts tailors cooperation to the unique needs of every AI startup.

Nordic Eye is a Venture & Growth Capital firm based in Copenhagen with representation in UK, US & Switzerland. We invest in carefully selected and mainly Nordic early-growth companies in the tech and lifestyle domain. We look for ambitious companies with high scalability and innovative business models. In addition to funding, our portfolio companies benefit from access to our talent, global network, and business relationships that can help validate their solutions and accelerate success in the market. Nordic Eye is a driving force behind innovation in the Nordics and California's technology and lifestyle space. Our global team aligns our interests with those of our investors and partners for lasting impact.

Seventure Partners is a long-term equity investor dedicated to supporting innovative companies that generate positive impacts on humankind, society, sustainability, and the planet. With €950 million in net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe, investing since 1997 in high-growth potential businesses across two main areas: Life sciences and Digital technologies. Our life sciences investments span biotech, health & digital health, nutrition, foodtech, blue economy, aquaculture, animal & agriculture, sport & wellness, with a particular focus on microbiome-related innovations across Europe, Israel, Asia, and North America. In the digital technologies sector, we invest in fintech, retailtech, and more, primarily in Western Europe.

ORBIT is a growth capital provider for successful scale-ups.Orbit Growth Equity invests in Europe's emerging stars that have reached the scale-up phase and are aiming for global expansion. We issue initial tickets ranging from €8-15 million and currently support four companies: Booksy, MEWS, Preply, and Rohlik.